Literature DB >> 29239042

Special types of thyroid carcinoma.

Zubair W Baloch1, Virginia A LiVolsi1.   

Abstract

This article reviews the small percentage of thyroid tumours that are not classified as classic papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma. It includes subtypes of papillary thyroid carcinoma, including, tall-cell, hobnail/micropapillary, columnar cell, diffuse sclerosing and solid variants. Poorly differentiated carcinoma, high-grade carcinoma and anaplastic thyroid carcinoma are reviewed. Also discussed are entities that are unusual but need to be recognized as primary thyroid neoplasms, i.e. mucoepidermoid carcinoma, sclerosing mucoepidermoid carcinoma with eosinophilia, and mammary analogue secretory carcinoma/secretory carcinoma. The pathological features and prognostic factors are described; a brief review of molecular correlates of these neoplasms is included.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  anaplastic; poorly differentiated; rare tumour; thyroid carcinoma; unusual tumour

Mesh:

Year:  2018        PMID: 29239042     DOI: 10.1111/his.13348

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  25 in total

Review 1.  2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer.

Authors:  Laura Fugazzola; Rossella Elisei; Dagmar Fuhrer; Barbara Jarzab; Sophie Leboulleux; Kate Newbold; Jan Smit
Journal:  Eur Thyroid J       Date:  2019-08-28

2.  Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer.

Authors:  Silvia Cantara; Eugenio Bertelli; Rossella Occhini; Marì Regoli; Lucia Brilli; Furio Pacini; Maria Grazia Castagna; Paolo Toti
Journal:  Endocrine       Date:  2019-02-14       Impact factor: 3.633

3.  Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.

Authors:  Rui-Zhi Gao; Qiao Que; Peng Lin; Yu-Yan Pang; Hua-Yu Wu; Xiao-Jiao Li; Gang Chen; Yun He; Hong Yang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 4.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

Review 5.  Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.

Authors:  Cristina Pizzimenti; Vincenzo Fiorentino; Antonio Ieni; Maurizio Martini; Giovanni Tuccari; Maria Lentini; Guido Fadda
Journal:  Endocrine       Date:  2022-07-21       Impact factor: 3.925

6.  Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway.

Authors:  Qun-Guang Jiang; Cheng-Feng Xiong; Yun-Xia Lv
Journal:  Mol Cell Biochem       Date:  2020-11-17       Impact factor: 3.396

7.  Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.

Authors:  Ling-Chuan Guo; Wei-Dong Zhu; Xiang-Yuan Ma; Hao Ni; En-Jian Zhong; Yang W Shao; Jie Yu; Dong-Mei Gu; Shun-Dong Ji; Hao-Dong Xu; Cheng Ji; Jin-Ming Yang; Yi Zhang
Journal:  Cancer Biol Ther       Date:  2018-09-25       Impact factor: 4.742

Review 8.  Pitfalls in Thyroid Cytopathology.

Authors:  Esther Diana Rossi; Adebowale J Adeniran; William C Faquin
Journal:  Surg Pathol Clin       Date:  2019-12

9.  GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.

Authors:  Mengyuan Li; Hongwei Jiang; Shengjiang Chen; Yujin Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.

Authors:  Yasuhiro Nihon-Yanagi; Megumi Wakayama; Naobumi Tochigi; Fumi Saito; Hideaki Ogata; Kazutoshi Shibuya
Journal:  J Thyroid Res       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.